Paradas C, Solano F, Carrillo F, Fernández C, Bautista J, Pintado E, Lucas M
Servicio de Neurología del Hospital, Universitario Virgen de Valme, Seville, Spain.
J Neurol. 2008 Jun;255(6):853-7. doi: 10.1007/s00415-008-0766-1. Epub 2008 May 2.
We examined families with a history of spinal and bulbar muscular atrophy (SBMA) and found that six out of eight female carriers had a skewed inactivation of the wild-type chromosome. Under these genetic conditions, disease manifestations should be expected and therefore we sought neurological and other symptoms of subclinical SBMA. We did not find either clinical symptoms or electrophysiological signs of mutated AR gene in female carriers, despite skewed methylation of the wild-type allele. These findings suggest that skewed methylation of AR genes are not necessarily associated to clinical manifestations in female carriers of the expanded SBMA allele.